Precision Epigenomics

09/13/2026

They’ve always looked out for you—now it’s your turn to look out for them.

Early detection is the most powerful tool we have in the fight against cancer. The EPISEEK multi-cancer early detection test provides a simple way to stay ahead of health shifts with precision screening. This Grandparents Day, let’s prioritize the health of the ones who raised us.

09/10/2026

Awareness saves lives, but early detection changes everything.
This Leukemia and Lymphoma Awareness Month, discover EPISEEK—the multi-cancer early detection test by Precision Epigenomics. One blood draw. Multiple insights. Infinite hope.
Find out how we’re redefining the fight against blood cancer at the link in our bio.

09/07/2026

This Labor Day, we’re celebrating the hard work you do every day by helping you find peace of mind. You work hard to provide for your family and build a future—let EPISEEK help you protect it.

Our multi-cancer early detection test is designed to find signals early, so you can get back to what matters most. Enjoy the day off knowing you're taking charge of your health.

09/03/2026

The future of health isn't about waiting for symptoms—it’s about getting ahead of them. Early detection is your most powerful defense, and with EPISEEK by Precision Epigenomics, you’re looking at the next generation of screening. By detecting cancer signals at the molecular level, often times before they present symptoms, you gain the most valuable asset in healthcare: time.

Take control of your wellness journey today. Because being proactive isn't just a choice—it's a game-changer.

09/01/2026

Today, we are proud to share new clinical validation data proving that our EPISEEK test significantly outperforms market alternatives across every critical operational and clinical metric.
By leveraging streamlined qPCR technology rather than complex Next-Generation Sequencing (NGS), EPISEEK® achieves a 58% observed sensitivity in early-stage (Stage I & II) cancers—nearly doubling the performance of legacy tests in the market (28% and 33%).
Read our full press release below to see how Precision Epigenomics is raising the standard for MCED performance.

https://precision-epigenomics.com/precision-epigenomics-announces-unprecedented-early-stage-sensitivity-data-for-episeek-multi-cancer-early-detection-test/

TUCSON, Ariz. — Sept 1, 2026 — Precision Epigenomics today announced new clinical validation data for its EPISEEK® test, an advanced Multi-Cancer Early Detection (MCED) liquid biopsy. The findings highlight EPISEEK’s superior sensitivity in early-stage cancer detection and its unique capabili...

09/01/2026

September is a busy month for cancer awareness: Childhood Cancer, Blood Cancers (Leukemia/Lymphoma), Prostate Cancer, Thyroid Cancer, and Gynecologic Cancers.

Instead of a dozen different tests, there’s EPISEEK. Our multi-cancer early detection technology looks for signals across a broad spectrum of cancers through a single blood draw. This month, we don’t just raise awareness; we provide a way to take action.

Don't wait for symptoms. Seek answers early.

08/27/2026

While cancer can affect anyone, the risk of incidence increases significantly as we cross the 45-year mark. That’s why we’ve designed EPISEEK as a vital tool for those 45 and older. By detecting signals early—often before symptoms even appear—you’re taking the ultimate proactive step for your future.

Don't wait for a sign. Seek the answer first.

08/25/2026

The "Wait and See" era of medicine is over. Standard screenings are vital, but they don't always give us the full picture.

With EPISEEK, we use advanced molecular science to detect cancer signals early—when they are most treatable.

The future of cancer care isn't just about treatment; it's about earlier detection.

08/20/2026

Is it watching your grandkids grow up? Finally taking that dream trip? Or simply enjoying more quiet mornings with the people you love?

Whatever it is, you owe it to your "why" to stay ahead of your health. The EPISEEK multi-cancer early detection test is designed to find what traditional screenings might miss.

Protect your future with EPISEEK-MCED today.

08/18/2026

Early detection just got easier. EPISEEK is designed to fit into your life and your schedule. Order through your healthcare provider or choose our white-glove telehealth service for a seamless, expert-guided experience from start to finish.

Take control of your health on your terms.